163 related articles for article (PubMed ID: 32733798)
1. 5-Aminolevulinic Acid Multispectral Imaging for the Fluorescence-Guided Resection of Brain Tumors: A Prospective Observational Study.
Charalampaki P; Proskynitopoulos PJ; Heimann A; Nakamura M
Front Oncol; 2020; 10():1069. PubMed ID: 32733798
[TBL] [Abstract][Full Text] [Related]
2. Analysis of 5-aminolevulinic acid-induced fluorescence in 55 different spinal tumors.
Millesi M; Kiesel B; Woehrer A; Hainfellner JA; Novak K; Martínez-Moreno M; Wolfsberger S; Knosp E; Widhalm G
Neurosurg Focus; 2014 Feb; 36(2):E11. PubMed ID: 24484249
[TBL] [Abstract][Full Text] [Related]
3. 5-Aminolevulinic acid-enhanced fluorescence-guided treatment of high-grade glioma using angled endoscopic blue light visualization: technical case series with preliminary follow-up.
Strickland BA; Wedemeyer M; Ruzevick J; Micko A; Shahrestani S; Daneshmand S; Shiroishi MS; Hwang DH; Attenello F; Chen T; Zada G
J Neurosurg; 2022 Nov; 137(5):1378-1386. PubMed ID: 35303704
[TBL] [Abstract][Full Text] [Related]
4. Quantitative fluorescence using 5-aminolevulinic acid-induced protoporphyrin IX biomarker as a surgical adjunct in low-grade glioma surgery.
Valdés PA; Jacobs V; Harris BT; Wilson BC; Leblond F; Paulsen KD; Roberts DW
J Neurosurg; 2015 Sep; 123(3):771-80. PubMed ID: 26140489
[TBL] [Abstract][Full Text] [Related]
5. Spectroscopic measurement of 5-ALA-induced intracellular protoporphyrin IX in pediatric brain tumors.
Schwake M; Kaneko S; Suero Molina E; Müther M; Schipmann S; Köchling M; Brentrup A; Stummer W
Acta Neurochir (Wien); 2019 Oct; 161(10):2099-2105. PubMed ID: 31435824
[TBL] [Abstract][Full Text] [Related]
6. Use of fluorescence to guide resection or biopsy of primary brain tumors and brain metastases.
Marbacher S; Klinger E; Schwyzer L; Fischer I; Nevzati E; Diepers M; Roelcke U; Fathi AR; Coluccia D; Fandino J
Neurosurg Focus; 2014 Feb; 36(2):E10. PubMed ID: 24484248
[TBL] [Abstract][Full Text] [Related]
7. A Comparative Analysis with Exoscope and Optical Microscope for Intraoperative Visualization and Surgical Workflow in 5-Aminolevulinic Acid-Guided Resection of High-Grade Gliomas.
Della Pepa GM; Mattogno P; Menna G; Agostini L; Olivi A; Doglietto F
World Neurosurg; 2023 Feb; 170():133-137. PubMed ID: 36400360
[TBL] [Abstract][Full Text] [Related]
8. Intra-operative visualization of brain tumors with 5-aminolevulinic acid-induced fluorescence.
Widhalm G
Clin Neuropathol; 2014; 33(4):260-78. PubMed ID: 24986206
[TBL] [Abstract][Full Text] [Related]
9. Impact of 5-aminolevulinic acid fluorescence-guided surgery on the extent of resection of meningiomas--with special regard to high-grade tumors.
Cornelius JF; Slotty PJ; Kamp MA; Schneiderhan TM; Steiger HJ; El-Khatib M
Photodiagnosis Photodyn Ther; 2014 Dec; 11(4):481-90. PubMed ID: 25117928
[TBL] [Abstract][Full Text] [Related]
10. 5-Aminolevulinic Acid Hydrochloride (5-ALA)-Guided Surgical Resection of High-Grade Gliomas: A Health Technology Assessment.
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2020; 20(9):1-92. PubMed ID: 32194883
[TBL] [Abstract][Full Text] [Related]
11. 5-Aminolevulinic acid for enhanced surgical visualization of high-grade gliomas: a prospective, multicenter study.
Schupper AJ; Baron RB; Cheung W; Rodriguez J; Kalkanis SN; Chohan MO; Andersen BJ; Chamoun R; Nahed BV; Zacharia BE; Kennedy J; Moulding HD; Zucker L; Chicoine MR; Olson JJ; Jensen RL; Sherman JH; Zhang X; Price G; Fowkes M; Germano IM; Carter BS; Hadjipanayis CG; Yong RL
J Neurosurg; 2022 Jun; 136(6):1525-1534. PubMed ID: 34624862
[TBL] [Abstract][Full Text] [Related]
12. Intraoperative 5-aminolevulinic acid-induced photodynamic diagnosis of metastatic brain tumors with histopathological analysis.
Yagi R; Kawabata S; Ikeda N; Nonoguchi N; Furuse M; Katayama Y; Kajimoto Y; Kuroiwa T
World J Surg Oncol; 2017 Sep; 15(1):179. PubMed ID: 28962578
[TBL] [Abstract][Full Text] [Related]
13. Endoscopic-assisted visualization of 5-aminolevulinic acid-induced fluorescence in malignant glioma surgery: a technical note.
Rapp M; Kamp M; Steiger HJ; Sabel M
World Neurosurg; 2014; 82(1-2):e277-9. PubMed ID: 23871813
[TBL] [Abstract][Full Text] [Related]
14. Confocal-Assisted Multispectral Fluorescent Microscopy for Brain Tumor Surgery.
Charalampaki P; Nakamura M; Athanasopoulos D; Heimann A
Front Oncol; 2019; 9():583. PubMed ID: 31380264
[TBL] [Abstract][Full Text] [Related]
15. Dual-labeling with 5-aminolevulinic acid and fluorescein for fluorescence-guided resection of high-grade gliomas: technical note.
Suero Molina E; Wölfer J; Ewelt C; Ehrhardt A; Brokinkel B; Stummer W
J Neurosurg; 2018 Feb; 128(2):399-405. PubMed ID: 28338432
[TBL] [Abstract][Full Text] [Related]
16. 5-ALA in Suspected Low-Grade Gliomas: Current Role, Limitations, and New Approaches.
Kiesel B; Freund J; Reichert D; Wadiura L; Erkkilae MT; Woehrer A; Hervey-Jumper S; Berger MS; Widhalm G
Front Oncol; 2021; 11():699301. PubMed ID: 34395266
[TBL] [Abstract][Full Text] [Related]
17. First in patient assessment of brain tumor infiltrative margins using simultaneous time-resolved measurements of 5-ALA-induced PpIX fluorescence and tissue autofluorescence.
Alfonso-García A; Zhou X; Bec J; Anbunesan SN; Fereidouni F; Jin LW; Lee HS; Bloch O; Marcu L
J Biomed Opt; 2022 Feb; 27(2):. PubMed ID: 35112514
[TBL] [Abstract][Full Text] [Related]
18. What is the Surgical Benefit of Utilizing 5-Aminolevulinic Acid for Fluorescence-Guided Surgery of Malignant Gliomas?
Hadjipanayis CG; Widhalm G; Stummer W
Neurosurgery; 2015 Nov; 77(5):663-73. PubMed ID: 26308630
[TBL] [Abstract][Full Text] [Related]
19. Cadherin 13 overexpression as an important factor related to the absence of tumor fluorescence in 5-aminolevulinic acid-guided resection of glioma.
Suzuki T; Wada S; Eguchi H; Adachi J; Mishima K; Matsutani M; Nishikawa R; Nishiyama M
J Neurosurg; 2013 Nov; 119(5):1331-9. PubMed ID: 24010971
[TBL] [Abstract][Full Text] [Related]
20. Intraoperative 5-ALA fluorescence-guided resection of high-grade glioma leads to greater extent of resection with better outcomes: a systematic review.
Eatz TA; Eichberg DG; Lu VM; Di L; Komotar RJ; Ivan ME
J Neurooncol; 2022 Jan; 156(2):233-256. PubMed ID: 34989964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
